Advanced search

Authors whose works are in public domain in at least one jurisdiction

Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 12 November 2012
Author/s

author: Laurence Zitvogel  Pierre Bruhns  Jeanette H Leusen  Marcello Albanesi 

Publication date November 12, 2012
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item